Skip to content

Ad-Lucem

Active
Private limited companyfounded 201511 yrs activeRue d'Angoussart 139, 1301 Wavre, BelgiumKBO/BCE: BE 0638.802.210
Summary

Ad-Lucem has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €295,991 and a net result of €36,822. Equity is growing by ~39.1% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

What they do
General medical practice
NACE 86210
1 site
How big
€318,262total assets 2024
Equity
€295,991
Profit
€36,822
Turnover not published (abridged schema)
Financially healthy?
95 Excellent Checked score 2024
Bankruptcy chance 12 m
0.1%
Who decides
Accounts 43 d early0 of 3 deeds read
Why 95- Higher-failure-rate region+ Lower-failure-rate sectorLatest accounts filed on timeShow the evidence

Checked score

Score 2024
Axes · tick = 2023
Profitability83▼-17
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 13.95 against 7.92 in 2023; short-term debt: 7% and cash: 42.9% of total assets), and 7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
43 d early
2024
45 d early
2023
47 d early
2022
35 d early
2021
4 d late
2020
24 d late
2019
43 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 18 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Caution: Result fell in 2024from €102,854 to €36,822 ▼ 64.2% View
  • Positive: 7 profitable years in a rowprofit 2024: €36,822 7 years View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Fiscal year
2024
Total assets
€318,262
Profit
€36,822
Solvency
93.0%
Total assets▼ 0.9%
Net result
20182024
Go to Financials

Timeline

Events
15
Since
2017
Next accounts
by 31-07-2027
  1. 18-06-2026Annual accounts filed
  2. 16-06-2025Annual accounts filed
  3. 14-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
24-09-2015
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.